Skip to content

Randomized Controlled Multicenter Clinical Observation of Danshi Jiangtang Capsules in Treating Type 2 Diabetic Foot Ulcers with Syndromes of Yin Deficiency and Blood Stasis

A Study on the Intensive Intervention Model for Diabetic Foot Ulcers Based on Xin'an Medicine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000243
Enrollment
Unknown
Registered
2025-02-13
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot Ulcer

Interventions

control group:Internal medicine basic treatment combined with surgical basic treatment
experimental group:On the basis of the control group add Danzhi Jiangtang capsules taken orally before meals 5 capsules (2.0 g) each time three times a day

Sponsors

The First Affiliated Hospital of Anhui University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with type 2 diabetes aged =18 and =75 years gender not limited; (2) Those with yin deficiency and blood stasis syndrome according to traditional Chinese medicine diagnosis; (3) Glycated hemoglobin (HbA1c) =9%; (4) Wagner classification of 1-2 with ulcer lesions below the ankle without exposure of tendons muscles joint capsules or bones and without signs of systemic infection; (5) The longest diameter of the ulcer lesion after debridement is =10 cm; if there are multiple ulcer lesions the largest area lesion is used as the observation lesion; (6) Ankle-brachial index (ABI) of the affected limb where the ulcer lesion is located is =0.6; (7) Those who voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Ulcers not related to diabetes such as rheumatic ulcers radiation ulcers and ulcers caused by vasculitis; (2) Ulcers with exposure of tendons muscles joint capsules or bones or the presence of sinus tracts that cannot be cleared by debridement; (3) Ulcer sites with severe clinical infections such as cellulitis or osteomyelitis accompanied by fever; (4) Patients with severe uncontrolled hypertension with systolic blood pressure =180 mmHg or diastolic blood pressure =110 mmHg; (5) Hemoglobin <10 g/dL; (6) Platelet count below the lower limit of normal; (7) Severe liver and kidney dysfunction; (8) Cancerous changes or malignant tumors in the ulcerated foot or patients suspected of having malignant tumors; (9) Use of any medication either orally or topically for the treatment of diabetic foot that promotes wound healing before participating in the study including traditional Chinese medicine or patent medicines that nourish yin and activate blood circulation; (10) Patients with allergic constitution or known

Design outcomes

Primary

MeasureTime frame
ulcer area healing rate;

Secondary

MeasureTime frame
Fasting blood glucose;Lower limb vascular color Doppler ultrasound examination;Traditional Chinese Medicine syndrome score;Four major lipid profiles;Postprandial blood glucose at 2 hours;Glycated hemoglobin;Ankle-Brachial Index;Foot X-ray imaging;

Countries

China

Contacts

Public ContactFang Zhaohui

The First Affiliated Hospital of Anhui University of Chinese Medicine

fangzhaohui9097@163.com13965059097

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026